Peer-influenced content. Sources you trust. No registration required. This is HCN.


Dana-Farber Cancer Institute

Dana-Farber Study Finds Up-front Chemotherapy Boost Could Benefit Patients with Non-Small Cell Lung Cancer

Oncology, Medical September 25th 2023

Roswell Park

Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer

Oncology, Medical September 19th 2023

Dana-Farber Cancer Institute

Final Overall Study Analysis Continues to Show Benefit of Sacituzumab Govitecan in Advanced HR+ Breast Cancer

Obstetrics & Gynecology September 11th 2023

Dana-Farber Cancer Institute

Dana-Farber AI-Model Predicts Primary Source of Cancer Using Gene Sequencing Data

Hematology/Oncology August 29th 2023


Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health

Ophthalmology August 23rd 2023

Northwestern Medicine

New Therapeutic Target for Parkinson’s Disease Discovered

Neurology August 22nd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form